CDD Thoughts on Data Sharing
As we enter the holidays, the season of giving and sharing, we here at CDD reflect on our commitment to broadening precompetitive collaboration and data sharing in the drug discovery ecosystem.
We see this as the necessary and sufficient condition for enabling the economics of specialization for both humanitarian and commercial drug discovery.
We are doing our small part along with a growing number of collaborators to promote a dialog on the importance of appropriate data sharing in the pharma and biotech arena. In the last few months we’ve published three articles. The first editorial, authored by Sean Ekins and our board member Alpheus Bingham, outlines features of industrial competitive collaboration. The second paper, co-authored with Antony Williams of the Royal Society of Chemistry focuses on sharing precompetitive ADME and toxicity related data on the web, as there is the potential to learn from the errors of others and not repeat them.
CDD has also published a paper in Touch Briefings – Drug Discovery Informatics with a focus on drug discovery moving to integrated web-based sharing tools.
This of course is in addition to abstracts at Keystone, Gordon, other major conferences, and our own annual community meeting in 2009. This year was a year of growth for CDD, from expanding our neglected disease work with the Gates Foundation, the release of CDD3, and broader pharmaceutical industry collaborations. We’re confident that in 2010, the industry (in particular the major biopharmaceutical companies) will continue to expand precompetitive and competitive collaborations, and we will certainly do our part to help.
We would like to wish our friends and collaborators around the globe happy holidays and look forward to even more exciting developments in 2010!